Ona Therapeutics

Barcelona biotech developing antibody-drug conjugates (ADCs) for hard-to-treat cancers, moving its lead asset into clinical development.

View on the globe

$86.6MEquity raised in 2025–20262025 — · 2026 $86.6M · 1 equity round
$86.6MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 4 Jun 2026 to 4 Jun 2026, $86.6M equity disclosed. Earlier rounds exist but are not sourced.4 Jun 2026: Series B, $86.6M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yet← earlier rounds not sourcedQ42026Q2Q3Q42027Equity round4 Jun 2026 · Series B · $86.6M · led by Columbus Venture Partners, Mérieux Equity PartnersVenture · $86.6M
Funding history: 1 round from 4 Jun 2026 to 4 Jun 2026, $86.6M equity disclosed. Earlier rounds exist but are not sourced.4 Jun 2026: Series B, $86.6M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yetearlier rounds not sourced2026Q2Q3Q42027Equity round4 Jun 2026 · Series B · $86.6M · led by Columbus Venture Partners, Mérieux Equity Partners$86.6M

Funding history 1 round · 1 source

Earlier rounds not yet sourced. Ona Therapeutics raised before 4 Jun 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series B
    Amount$86.6M
    Post-money—
    ✓ Confirmed
    Lead
    Columbus Venture Partners, Mérieux Equity Partners
    Also
    COFIDES, Korys, Alta Life Sciences, Asabys Partners, Bpifrance, CDTI, FundPlus NV, Ysios Capital
    Note
    Oversubscribed Series B announced by the company (GlobeNewswire original returned 403; copy read via BioSpace). USD 86.6M stated; no EUR figure in the release (Catalan press reports EUR 74.2M at conversion). Valuation not stated (pre/post not stated). A Pulse 2.0 mention of Seventure Partners as lead contradicts the release and was not used. Investor list: 'CDTI (via SICC Innvierte)' shortened to CDTI; the Innvierte channel is not recorded.
    Sources
  2. Earlier rounds not yet sourced

Investors 10

  • Columbus Venture Partners1
  • Mérieux Equity Partners1
  • Alta Life Sciences
  • Asabys Partners
  • Bpifrance
  • CDTI
  • COFIDES
  • FundPlus NV
  • Korys
  • Ysios Capital

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Also in the Barcelona hub see on the globe

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Ona Therapeutics and its logo are trademarks of their owners, used here for identification only.